HealthQuad closes second fund, raised Rs 1215 crores, led by global pharma giant MSD MD Bureau31 March 2022 12:02 PM GMTHealthQuad, India's leading healthcare venture capital fund, has announced the final close of its second fund, HealthQuad Fund-II, with a total...
Vietnam says Pfizer, MSD to grant its firms licenses to produce COVID pills Medical Dialogues Bureau26 Nov 2021 6:15 AM GMTHanoi: Drugmakers Pfizer Inc and MSD, known as Merck & Co Inc in North America, have agreed to give licenses to firms in Vietnam to produce...
Sun Pharma to launch Molnupiravir under brand name Molxvir in India Ruchika Sharma12 Nov 2021 6:30 AM GMTMumbai: Sun Pharmaceutical Industries Limited has recently said that the company is gearing up to introduce Merck Sharpe Dohme (MSD) and Ridgeback's...
Patent Infringement: MSD sues firm in Delhi HC over diabetes drug Sitagliptin Medical Dialogues Team20 Jun 2021 6:00 AM GMTNew Delhi: In a major victory for Merck Sharp and Dohme (MSD) Corp, the Delhi High Court has restrained Solitaire Pharmacia Private from infringing...
Delhi HC Restrains Firm From Infringing on MSD Diabetes Drug Sitagliptin Medical Dialogues Team8 Jun 2021 3:06 PM GMTNew Delhi: In a major relief to Merck Sharp & Dohme Corp, the Delhi High Court has barred YMS Laboratories Private Limited from infringing on...
Merck inks licensing pact with Cipla, Sun Pharma, 3 others for oral COVID drug Molnupiravir Medical Dialogues Team28 April 2021 6:21 AM GMTMumbai: In order to accelerate and expand global access to Molnupiravir for treating Covid-19, Merck (known as MSD Pharmaceuticals outside the United...
